Published by Coherent Market Insights
Posted on September 30, 2021
4 min readLast updated: February 1, 2026
The Urinalysis Market is set to grow at a 5.2% CAGR, reaching $1,779.9 Mn by 2027, driven by rising health concerns and technological advancements.
Urinalysis Market (Forecast Period 2021-2028): The report provides a valuable source of insightful data for business strategists and competitive analysis of Urinalysis Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.
To Access the Sample Report Click Here: https://www.coherentmarketinsights.com/insight/request-sample/382
Note: *The Sample only consist of Table of Content (ToC), Research Framework of the actual report, and Research Methodology adopted for it.
Major Players In This Market Are: Alere, Bio Rad, Roche Diagnostics, Mindray, Arkray, Inc., Sysmex, and Siemens Healthcare.
In July 2021, WADA (World Anti-Doping Agency) mandated the urinalysis testing for athletes participating in the Olympics Games Tokyo 2021 to curb the illegal use of marijuana. The urinalysis is an individual set of diagnostic tests which are used to detect certain urinary conditions. It can be utilized to screen for urinary disorders and/or to diagnose conditions like bladder infections, kidney infections, bladder disorders, diabetes or other such metabolic disorders. The diagnostic process of the urinalysis usually involves collecting urine from the patient and examining it under a microscope to identify the parameters of the condition for which it was drawn. Normally, there are four factors which are used in the medical procedure of urinalysis: color, odor, struvite components, and protein concentration.
Color evaluation of the urine sample reveals the nature of the composed particles. Different elements have different concentrations, and it is these elements that are seen in the urine on examination. The dominant color of the urine sample is green, indicating the presence of relatively lighter cells (red cells). The size, shape, number of the cells, and the content of the various components in the sample of urinalysis can provide additional information about the specimen.
Another method of determining abnormal findings in the urinary samples is the microscopic examination of the specimen under a microscope. There are a variety of reasons why microscopic examination is used in the clinical laboratory of urinalysis. The microscopic examination of the sample helps to determine the specific type of microorganism responsible for the abnormal findings. In addition, the characteristic cells of the appropriate type of microorganism can be identified on microscopic examination. In July 2021, a laboratory automation providing company, Inpeco, launched FlexLab Laboratory Automation System for urinalysis and fertility testing solutions.
The urinalysis market is anticipated to increase due to factors such as rising worldwide incidence of kidney illnesses and UTIs (urinary tract infections), rising health concerns connected with the elderly population, and the development of technically savvy equipment. In addition, increasing practice of fertility and pregnancy testing at an early stage in clinics is also creating positive prospects for the urinalysis market. On the contrary, poor healthcare facilities and awareness over urinalysis testing in the developing countries can create a hindrance in the expansion of the urinalysis market.
In the territorial breakdown, the urinalysis market in the North American region is foreseen to augment at a significant rate owing to the rising practice of urinalysis testing for health check-ups in clinics. Additionally, the Asia Pacific is also emerging a lucrative region for the urinalysis market in the view of increasing awareness of personalized testing coupled with the growing geriatric population.
Buy This Premium Report Of Urinalysis Market Report 2021 With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/382
In this study, the years considered to estimate the market size of Urinalysis are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2028
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Urinalysis Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Urinalysis Market are also given.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Urinalysis Market Size and Share Is Projected To Reach US$ 1,779.9 Mn at a 5.2% CAGR By 2027 | Future Trends, Application, Key Players and Global Industry Insights appeared first on Gatorledger.
The article focuses on the growth and trends of the Urinalysis Market, projected to reach $1,779.9 Mn by 2027.
Key players include Alere, Bio Rad, Roche Diagnostics, Mindray, Arkray, Inc., Sysmex, and Siemens Healthcare.
Rising incidence of kidney illnesses, UTIs, and advancements in urinalysis technology are key growth drivers.
Explore more articles in the Research Reports category
